Asia-Pacific Congress on Lung Cancer in conjunction with the 10th TCOG Annual Meeting

Dec. 2 – 3, 2006

Topic Speaker
National Research Program for Genomic Medicine Mechanisms of Metastasis and Progression of Lung Cancer Pan-Chyr Yang 
Regulation of CRMP-1 by Protein Interaction Networks and Phosphorylation to Monitor the Completion of Cytokinesis in Lung Cancer Cells Chi-Ying F. Huang 
Prognostic and Predictive Molecular Markers for Adjuvant Therapy in Early Stage NSCLC Ming-Sound Tsao
EGFR Mutations and Predictive Markers for EGFR TKI Therapy in Treatment of Non-small Cell Lung Cancer Tetsuya Mitsudomi
Ethnic Differences in the Treatment of Non-small Cell Lung Cancer with EGFR Tyrosine Kinase Inhibitors Masahiro Fukuoka
Outcomes of Curative Resection for Pathologic Stage I Non-small Cell Lung Cancer: A 20-year Analysis Wen-Hu Hsu 
Surgical Treatment for Multiple Primary Lung Cancer Yung-Chie Lee 
The Role of VATS in Lung Cancer Surgery Hui-Ping Liu 
Special Situation of Lung Cancer Surgery Ming-Ho Wu 
Reoperation for Lung Cancer: Experience with 31 Cases Nan-Yung Hsu 
The Trend of Application of the Molecular Biology in the Treatment Plan for Lung Cancer Patients Biing-Shiun Huang 
Innovative Clinical Trials for Non-small Cell Lung Cancer at NCC Korea Jin-Soo Lee
Non-small Cell Lung Cancer: Strategies to Change Natural Course of Disease and Improve Survival Alex Yuang-Chi Chang
Molecular Signatures of Non-small Cell Lung Cancer David P. Carbone
Patient Selection for EGFR Therapy Paul A. Bunn, Jr.
Treatment Strategy in Advanced NSCLC Paul A. Bunn, Jr.
Genome-wide Chromosomal Deletion and Promoter Hypermethylation and Their Clinical Implications in Lung Cancer Yi-Ching Wang 
Chemosensitivity of Non-small Cell Lung Cancer Cells or Patients with Wild Type or Activated Mutation of Epidermal Growth Factor Receptors Chih-Hsin Yang 
Epigenetic Changes in Lung Cancer James Herman
Share Button

Comments are closed.